Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.07 USD | -7.59% | -14.81% | -31.23% |
06-24 | Omega Therapeutics, Inc. Appoints Richard N. Kender to Board of Directors | CI |
06-18 | Raymond James Initiates Omega Therapeutics at Outperform Rating With $12 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bearish | Neutral |
Resistance | 2.470 | 2.885 | 5.680 |
Spread/Res. | -16.19% | -28.25% | -63.56% |
Spread/Supp. | +11.29% | +11.29% | +38.00% |
Support | 1.860 | 1.860 | 1.500 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- OMGA Stock
- Charts Omega Therapeutics, Inc.